PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.\', \'World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.\', \'Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York.\', \'Department of Public Health, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.\', \'Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar.\', \'Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.\', \'Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.\', \'Department of Pathology, Sidra Medicine, Doha, Qatar.\', \'Hamad Medical Corporation, Doha, Qatar.\', \'Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom.\', \'College of Health Sciences, QU Health, Qatar University, Doha, Qatar.\', \'Primary Health Care Corporation, Doha, Qatar.\', \'Ministry of Public Health, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jama.2021.19623
?:doi
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 34724027
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all